Literature DB >> 3760573

Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants.

J M Wang, G J Cianciolo, R Snyderman, A Mantovani.   

Abstract

Two sets of seemingly contradictory evidence have been reported concerning the effects of tumor cell products on the regulation of monocyte migration in vitro and presumably the extravasation of macrophages into tumors in vivo. The present study was designed to explore the relationship between chemotactic and anti-chemotactic products related to tumor cells: a tumor-derived chemotactic factor (TDCF) and retroviral P15E-related inhibitor(s) of chemotaxis. Culture supernatants of the human 8387 sarcoma and SW626 ovarian carcinoma were depleted of P15E-related antigens with immobilized anti-P15E monoclonal antibodies. This treatment produced a significant and consistent increase of the polarizing and chemotactic activity in the tumor cell supernatants. The material eluted from Sepharose-bound anti-P15E antibodies was devoid of chemotactic and polarizing activity and suppressed the polarization and migration of monocytes in response to chemoattractants. These results demonstrate the coexistence in culture supernatants of two human tumor cell lines of factors with opposite influences on monocyte chemotaxis. The data suggest that the entry of monocytes into neoplastic tissue may be regulated by the interplay of chemotactic and anti-chemotactic principals produced by tumor cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3760573

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Sequence variation of human endogenous retrovirus ERV9-related elements in an env region corresponding to an immunosuppressive peptide: transcription in normal and neoplastic cells.

Authors:  M Lindeskog; P Medstrand; J Blomberg
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

2.  Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor.

Authors:  Giada Frascaroli; Stefania Varani; Nina Blankenhorn; Robert Pretsch; Michael Bacher; Lin Leng; Richard Bucala; Maria Paola Landini; Thomas Mertens
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

3.  Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide.

Authors:  M Nelson; D Nelson
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells.

Authors:  S Huang; R K Singh; K Xie; M Gutman; K K Berry; C D Bucana; I J Fidler; M Bar-Eli
Journal:  Cancer Immunol Immunother       Date:  1994-10       Impact factor: 6.968

5.  Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line.

Authors:  C O Zachariae; A O Anderson; H L Thompson; E Appella; A Mantovani; J J Oppenheim; K Matsushima
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

6.  Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants.

Authors:  T Yoshimura; E A Robinson; S Tanaka; E Appella; J Kuratsu; E J Leonard
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

7.  Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.

Authors:  Myriam Estko; Stephan Baumgartner; Konrad Urech; Matthias Kunz; Ursula Regueiro; Peter Heusser; Ulrike Weissenstein
Journal:  BMC Complement Altern Med       Date:  2015-04-24       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.